MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it received Premarket Approval (PMA) from the U.S. Food and Drug ...
DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results